ClinConnect ClinConnect Logo
Search / Trial NCT01902589

Resistance of Helicobacter Pylori to Antibiotics in Children

Launched by HAEMEK MEDICAL CENTER, ISRAEL · Jul 16, 2013

Trial Information

Current as of August 27, 2025

Completed

Keywords

ClinConnect Summary

The aim of our prospective study is to investigate the rate of H pylori resistant strains to antibiotic treatment including Amoxicillin, Clarithromycin, Metronidazole, Tetracycline and Quinolones in pediatric population in Ha-Emek medical center, Afula. The second aim was to determine if in vitro resistance is being reflected in vivo too.

Should the investigators find high rates of H pylori resistance to Clarithromycin, the investigators will have to reconsider the recommendation to use Clarithromycin as the first line treatment for H pylori.

Our research group will conclude 100 children ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ages of 1-18 years,
  • evaluated for recurrent abdominal pain,
  • iron deficiency anemia,
  • failure to thrive by an upper endoscopy

About Haemek Medical Center, Israel

Haemek Medical Center, located in Israel, is a leading healthcare institution renowned for its commitment to advancing medical research and patient care. With a strong emphasis on clinical trials, the center collaborates with multidisciplinary teams to explore innovative treatments and therapies across various medical fields. Haemek Medical Center is dedicated to maintaining high ethical standards and regulatory compliance, ensuring the safety and well-being of participants while contributing valuable insights to the global medical community. Through its robust research programs and state-of-the-art facilities, the center aims to enhance healthcare outcomes and foster scientific advancements.

Locations

Afula, , Israel

Patients applied

0 patients applied

Trial Officials

Sarit Peleg, MD

Principal Investigator

Ha'Emek Medical Center, Afula, Israel

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials